Lumira Ventures is a venture capital firm that specializes in investments in the life sciences sector, including biotechnology, pharmaceuticals, and healthcare IT. The firm focuses on early-stage companies with innovative technologies and therapeutics that have the potential to address significant unmet medical needs.

Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer and more productive lives.

Lumira Ventures

Looking forward to #THT2024 in Boston and a number of clinical data readouts from Lumira Ventures' portfolio companies innovating the standard of care for heart failure.  

Looking forward to seeing some of you at the BIO CEO & Investor Conference in New York City this week.  

Canadian business, #healthcare, #government and #academic communities have developed many of the ingredients needed to create a world-class #healthcare #innovation ecosystem, but there is still work to be done.

We explore this and other key topics in this discussion with Peter van der Velden, Jacki Jenuth and Suman Rao of Lumira Ventures. https://bit.ly/49cQ1yF

Major Milestone: Lumira portfolio company, Iterion Therapeutics, has dosed the first patient in the phase 1b/2a clinical trial of Tegavivint in advanced hepatocellular carcinoma.

Read more: https://bit.ly/3ORo8UH

Lumira Ventures was among over 15 new and existing investors participating in the $200M oversubscribed private placement financing of our portfolio company enGene (Nasdaq: ENGN). The financing will help fund the company's operating plan into 2027.

Read more: https://bit.ly/4bFPCXa


COM:LUMIRAVENTURES

Lumira Ventures

Analysis Not Available